scholarly journals Incidence of cardiovascular disease up to 13 year after cancer diagnosis: A matched cohort study among 32 757 cancer survivors

2018 ◽  
Vol 7 (10) ◽  
pp. 4952-4963 ◽  
Author(s):  
Dounya Schoormans ◽  
Pauline A. J. Vissers ◽  
Myrthe P. P. van Herk-Sukel ◽  
Johan Denollet ◽  
Susanne S. Pedersen ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Cohort Study ◽  
Cancer Survivors ◽  
Cancer Diagnosis ◽  
Matched Cohort ◽  
Matched Cohort Study ◽  
After Cancer

Increased risk for psychiatric disorders immediately before and after cancer diagnosis: A nationwide matched cohort study in Sweden

2015 ◽  
Vol 61 ◽  
pp. 50
Author(s):  
Donghao Lu ◽  
Therese M.-L. Andersson ◽  
Katja Fall ◽  
Christina M. Hultman ◽  
Kamila Czene ◽  
...  
Keyword(s):  
Cohort Study ◽  
Psychiatric Disorders ◽  
Cancer Diagnosis ◽  
Matched Cohort ◽  
Matched Cohort Study ◽  
Increased Risk ◽  
Before And After ◽  
After Cancer

scholarly journals Diabetes care management patterns before and after a cancer diagnosis: A SEER‐Medicare matched cohort study

Cancer ◽  
2020 ◽  
Vol 126 (8) ◽  
pp. 1727-1735 ◽  
Author(s):  
Laura C. Pinheiro ◽  
Orysya Soroka ◽  
Lisa M. Kern ◽  
John P. Leonard ◽  
Monika M. Safford
Keyword(s):  
Cohort Study ◽  
Cancer Diagnosis ◽  
Diabetes Care ◽  
Care Management ◽  
Matched Cohort ◽  
Matched Cohort Study ◽  
Before And After

scholarly journals Cardiovascular disease in kidney donors: matched cohort study

BMJ ◽  
2012 ◽  
Vol 344 (mar01 2) ◽  
pp. e1203-e1203 ◽  
Author(s):  
A. X. Garg ◽  
A. Meirambayeva ◽  
A. Huang ◽  
J. Kim ◽  
G. V. R. Prasad ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Cohort Study ◽  
Matched Cohort ◽  
Kidney Donors ◽  
Matched Cohort Study

Long-term cervical cancer survivors suffer from pelvic floor symptoms: A cross-sectional matched cohort study

2010 ◽  
Vol 117 (2) ◽  
pp. 281-286 ◽  
Author(s):  
M.H. Hazewinkel ◽  
M.A.G. Sprangers ◽  
J. van der Velden ◽  
C.H. van der Vaart ◽  
L.J.A. Stalpers ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cohort Study ◽  
Pelvic Floor ◽  
Cancer Survivors ◽  
Matched Cohort ◽  
Cross Sectional ◽  
Matched Cohort Study ◽  
Pelvic Floor Symptoms

scholarly journals Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: a matched cohort study using linked English electronic health records data

2020 ◽  
Author(s):  
Helena Carreira ◽  
Helen Strongman ◽  
Maria Peppa ◽  
Helen I McDonald ◽  
Isabel dos-Santos-Silva ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cohort Study ◽  
Electronic Health Records ◽  
Cancer Survivors ◽  
Cancer Diagnosis ◽  
Risk Groups ◽  
Matched Cohort ◽  
Health Records ◽  
Severe Influenza ◽  
Clinical Risk Groups

AbstractBackgroundPeople with active cancer are recognised as at risk of COVID-19 complications, but it is unclear whether the much larger population of cancer survivors is at elevated risk. We aimed to address this by comparing cancer survivors and cancer-free controls for (i) prevalence of comorbidities considered risk factors for COVID-19; and (ii) risk of severe influenza, as a marker of susceptibility to severe outcomes from epidemic respiratory viruses.MethodsWe included survivors (≥1 year) of the 20 most common cancers, and age, sex and general practice-matched cancer-free controls, derived from UK primary care data linked to cancer registrations, hospital admissions and death registrations. Comorbidity prevalences were calculated 1 and 5 years from cancer diagnosis. Risk of hospitalisation or death due to influenza was compared using Cox models adjusted for baseline demographics and comorbidities.Findings108,215 cancer survivors and 523,541 cancer-free controls were included. Cancer survivors had more asthma, other respiratory, cardiac, diabetes, neurological, renal, and liver disease, and less obesity, compared with controls, but there was variation by cancer site. There were 205 influenza hospitalisations/deaths, with cancer survivors at higher risk than controls (adjusted HR 2.78, 95% CI 2.04-3.80). Haematological cancer survivors had large elevated risks persisting for >10 years (HR overall 15.17, 7.84-29.35; HR >10 years from cancer diagnosis 10.06, 2.47-40.93). Survivors of other cancers had evidence of raised risk up to 5 years from cancer diagnosis only (HR 2.22, 1.31-3.74).InterpretationRisks of severe COVID-19 outcomes are likely to be elevated in cancer survivors. This should be taken into account in policies targeted at clinical risk groups, and vaccination for both influenza, and, when available, COVID-19, should be encouraged in cancer survivors.FundingWellcome Trust, Royal Society, NIHR.Research in contextEvidence before this studyFew data are available to date on how COVID-19 affects cancer survivors. We searched PubMed with the keywords “influenza cancer survivors” to identify studies that compared severe influenza outcomes in cancer survivors and in a control group. No study was identified.Added value of this studyIn this matched cohort study of routinely collected electronic health records, we demonstrated raised risks of influenza hospitalisation or mortality in survivors from haematological malignancies for >10 years after diagnosis, and in survivors from solid cancers up to 5 years after diagnosis.Implications of all the available evidenceCancer survivorship appears to be an important risk factor for severe influenza outcomes, suggesting that cancer survivors may also be at raised risk of poor COVID-19 outcomes. This should be taken into account in public health policies targeted at protecting clinical risk groups. Influenza vaccination should be encouraged in this group, and may need to be extended to a wider population of medium- to long-term cancer survivors than currently recommended.

Long-term risk of cardiovascular disease among colorectal cancer survivors in a population-based cohort study.

2018 ◽  
Vol 36 (7_suppl) ◽  
pp. 113-113 ◽  
Author(s):  
David Baraghoshi ◽  
Makenzie L. Hawkins ◽  
Sarah Abdelaziz ◽  
Jihye Park ◽  
Yuan Wan ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cardiovascular Disease ◽  
Cancer Survivors ◽  
Cancer Diagnosis ◽  
Cvd Risk ◽  
Colorectal Cancer Survivors ◽  
Increased Risk ◽  
After Cancer

113 Background: In the United States, colorectal cancer is the fourth most common cancer and one of the leading causes of cancer death. Few studies have examined the relationship between colorectal cancer survivorship and long-term cardiovascular disease (CVD) risk. Methods: Individuals diagnosed with colorectal cancer were identified using the Utah Population Database. For a comparison group, up to 5 cancer-free individuals were matched by birth year, birth state, follow-up time and sex to each cancer case. For individuals with > 10 years of follow-up, we estimated CVD risk > 10 years after cancer diagnosis. Cox regression models were used to estimate hazard ratios (HR) and 95% Confidence Intervals. Results: Among 1,749 colorectal cancer survivors who had survived for at least 10 years, 1,001 (57.2%) were diagnosed with CVD > 10 years after cancer diagnosis. Compared to the general population, colorectal cancer survivors had an increased risk of CVD > 10 years after cancer diagnosis: HR = 2.84 (95% CI = 2.59, 3.11) for hypertension; HR = 2.66 (95% CI 2.37, 2.98) for diseases of the heart; HR = 3.91 (95% CI = 3.33, 4.58) for diseases of the arteries, arterioles and capillaries; HR = 2.58 (95% CI = 2.46, 2.99) for diseases of the veins and lymphatics; HR = 2.98 (95% CI = 2.36, 3.76) for cerebrovascular disease. Colorectal cancer survivors with ≥1 comorbidity had an increased risk of CVD > 10 years after cancer diagnosis compared to survivors with no comorbidities (HR = 1.7, 95% CI = 1.49, 1.95). Colorectal cancer survivors who were ≥65 years had an increased risk of CVD > 10 years after cancer diagnosis. Colorectal cancer survivors who were obese at the time of diagnosis had an increased risk of CVD > 10 years after cancer diagnosis when compared to survivors with normal BMIs (HR = 1.25; 95% CI = 1.06, 1.49). Conclusions: Compared to the general population, colorectal cancer survivors had an increased risk of CVD during the > 10 year follow-up period. Within colorectal cancer survivors, there was an increased risk of CVD for those that were older, had ≥1 comorbidity and were obese. The increased risk of CVD among survivors may be attributable to the lifestyle risk factors shared by colorectal cancer and CVD.

scholarly journals Cancer diagnosis and risk of suicide after accounting for prediagnosis psychiatric care: A matched‐cohort study of patients with incident solid‐organ malignancies

Cancer ◽  
2019 ◽  
Author(s):  
Zachary Klaassen ◽  
Christopher J.D. Wallis ◽  
Thenappan Chandrasekar ◽  
Hanan Goldberg ◽  
Rashid K. Sayyid ◽  
...  
Keyword(s):  
Cohort Study ◽  
Cancer Diagnosis ◽  
Psychiatric Care ◽  
Solid Organ ◽  
Matched Cohort ◽  
Matched Cohort Study
Sign in / Sign up

Export Citation Format

Share Document